Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism
- 21 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 19 (9) , 3825-3836
Abstract
Pancreatic cancer (PC) is becoming one of the deadliest cancers, with mortality among the highest worldwide because of its pathogenic latency and the lack of efficient drugs in the clinic. Considering that cancer cells undergo proliferation and differentiation at substantial metabolic costs, as indicated by dysregulated glycolysis and an abnormal TCA cycle induced by mitochondrial damage, we investigated the therapeutic capacity of berberine (BBR) in pancreatic cancer using a cell metabolomics method. A phenotypic assay revealed the significant inhibitory role of BBR on PC cell viability and metastasis. In addition, a precision-targeted metabolome assay showed that BBR profoundly dysregulated the energy metabolism of PC cells, and phenotypic observations based on imaging indicated that PC cell mitochondria were markedly damaged after BBR treatment. Notably, citrate metabolism and transportation in cell mitochondria were significantly influenced by BBR, which led to the blocked biosynthesis of the defined fatty acids (FAs) through the regulation of ACLY, ACO1 and SLC13A5. Therefore, the regulatory effects of FAs on PC cell proliferation and metastasis may be regulated by BBR through targeting citrate metabolism. Collectively, our in vitro data preliminarily reveals the therapeutic potential of BBR against pancreatic cancer by targeting citrate metabolism, citrate might be a new target for drug development and the treatment against PC, but further experimental verification will be required subsequently; Moreover, our study demonstrated cell metabolomics method pertains the capacity to rapidly explore biochemical function of natural products.Keywords
Funding Information
- Shanghai Jiao Tong University (WF220441502)
- Ministry of Science and Technology of the People's Republic of China (2017YFC1308600, 2017YFC1308605)
- National Natural Science Foundation of China (31670031)
This publication has 69 references indexed in Scilit:
- Cerebral metabonomics study on Parkinson's disease mice treated with extract of Acanthopanax senticosus harmsPhytomedicine, 2013
- Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC‐ESI MS combined with pattern recognition methodsLiver International, 2013
- Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing FactorPLOS ONE, 2012
- The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancerBritish Journal of Cancer, 2011
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor GenesScience, 2010
- Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMSJournal of Pharmaceutical and Biomedical Analysis, 2010
- Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophageCell Research, 2009
- ATP Citrate Lyase: Activation and Therapeutic Implications in Non–Small Cell Lung CancerCancer Research, 2008
- Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemiaProceedings of the National Academy of Sciences, 2008
- Chemistry and Biology of Terpene Trilactones fromGinkgo BilobaAngewandte Chemie International Edition, 2004